50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

US accuses CVS of filling, billing government for illegal opioid prescriptions

Published 12/18/2024, 03:22 PM
Updated 12/19/2024, 04:45 AM
© Reuters. FILE PHOTO: A screen displays the logo and trading information for CVS Health on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 6, 2023.  REUTERS/Brendan McDermid/File photo
CVS
-

By Brendan Pierson

(Reuters) -The U.S. Department of Justice announced a lawsuit on Wednesday accusing pharmacy chain CVS of filling illegal opioid prescriptions and billing federal health insurance programs, contributing to a nationwide epidemic of opioid addiction and overdose.

The newly unsealed complaint in Providence, Rhode Island federal court alleges that, from October 2013 to the present, CVS violated the federal Controlled Substances Act by filling prescriptions for dangerous quantities of opioids and dangerous combinations of drugs.

It said the company regularly filled prescriptions from doctors running so-called pill mills, dispensing large quantities of opioids without legitimate medical reason.

The Justice Department said the violations were driven by company-mandated performance metrics that led to red flags being ignored, and that in some cases patients died of overdoses shortly after filling illegal prescriptions.

"We have cooperated with the DOJ's investigation for more than four years, and we strongly disagree with the allegations and false narrative within this complaint," CVS said in a statement.

CVS agreed in 2022 to pay close to $5 billion over 10 years to settle thousands of similar claims by state, local and Native American tribal governments. It did not admit wrongdoing under the deal, which was one of a series of nationwide settlements by pharmacies, drugmakers and distributors totaling about $46 billion.

The Justice Department's lawsuit unsealed on Wednesday began as a whistleblower complaint brought by a former CVS employee.

According to the lawsuit, CVS maintained inadequate staffing and pushed its pharmacists to fill prescriptions as quickly as possible without investigating whether they were legitimate, and ignored warnings from its own employees.

"Safety issues arise when one is dealing with medication and also being rushed to fulfill an order like McDonald's (NYSE:MCD)," one employee allegedly wrote. "CVS has concocted an assembly-line style of medication preparation and only cares about profits."

The company continued to fill hundreds of prescriptions for one Alabama doctor even after multiple internal notes warned in 2015 that he was under investigation, the complaint said. That doctor was arrested in 2016.

It filled thousands of prescriptions for a Pennsylvania doctor despite internal warnings and online patient reviews saying he "writes scripts without seeing the patient" and is "a pill pusher, and a drunk," the Justice Department said.

© Reuters. FILE PHOTO: A screen displays the logo and trading information for CVS Health on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 6, 2023.  REUTERS/Brendan McDermid/File photo

The complaint described 10 individual patients who died, allegedly after filling illegal prescriptions for opioids and other drugs at CVS.

More than 800,000 people in the United States died of opioid overdoses from 1999 through 2023, according to data from the U.S. Centers for Disease Control and Prevention. Preliminary data shows overdoses began to decrease last year.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.